Pharma Journalist - Page 102 of 957 -

Cognizant Extends Gilead Partnership to Expand AI-Enabled DevOps

CSL, Alentis Partner on $1.55B Kidney and Liver Drug

Alector Licenses Parkinson’s Drug Program to Genentech for $1.27B

Astellas Licenses XNW27011 ADC from Evopoint Biosciences

Teva’s Celiac Disease Drug Receives FDA Fast Track Designation

Biogen and City Therapeutics Launch Collaboration to Develop RNAi-Based Therapies

Coherus and STORM Therapeutics Partner to Evaluate STC-15 with LOQTORZI in Clinical Trial

AskBio Publishes Full Phase 1b Results for Parkinson’s Gene Therapy AB-1005

FDA Grants Priority Review to Otsuka’s Sibeprenlimab for IgAN

Lupin, SteinCares Ink Ranibizumab Deal for Latin America

Lilly Boosts Pain Pipeline with SiteOne Therapeutics Acquisition

Spotlight on Emerging Innovators: The 2025 Start-Up Showcase

Health Canada to Review GSK’s Depemokimab for Asthma and Nasal Polyps